Cargando…

Monitoring of incidence, severity, and causality of adverse drug reactions in hospitalized patients with cardiovascular disease

BACKGROUND: Patients admitted to cardiology department are mostly on polypharmacy. So drug-drug interactions and adverse effects of drugs are quite common. Yet, there is a paucity of data regarding adverse drug reaction (ADR) monitoring in cardiology department in India. The present study is an effo...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaur, Sharminder, Kapoor, Vinod, Mahajan, Rajiv, Lal, Mohan, Gupta, Seema
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062114/
https://www.ncbi.nlm.nih.gov/pubmed/21455416
http://dx.doi.org/10.4103/0253-7613.75661
_version_ 1782200690969411584
author Kaur, Sharminder
Kapoor, Vinod
Mahajan, Rajiv
Lal, Mohan
Gupta, Seema
author_facet Kaur, Sharminder
Kapoor, Vinod
Mahajan, Rajiv
Lal, Mohan
Gupta, Seema
author_sort Kaur, Sharminder
collection PubMed
description BACKGROUND: Patients admitted to cardiology department are mostly on polypharmacy. So drug-drug interactions and adverse effects of drugs are quite common. Yet, there is a paucity of data regarding adverse drug reaction (ADR) monitoring in cardiology department in India. The present study is an effort to fill up these lacunae. MATERIALS AND METHODS: A prospective, observational study registering 966 indoor cardiology patients according to predetermined inclusion and exclusion criteria was conducted for one year. ADR profile was noted by spontaneous reporting and intensive monitoring. Naranjo ADR probability scale was used to establish the causality. RESULTS: A total of 208 ADRs were reported from 188 patients (19.5%). Of these 188 patients, 62 patients (33%) were hospitalized primarily due to the development of ADRs, while 126 (67%) patients developed ADRs during hospital stay. Nitrates were the most common offender drug group (17.8%). CONCLUSION: Development of ADR in one of every five cardiac patient points toward a grave situation, but a higher incidence of Type A reactions in cardiology department means that these can be avoided.
format Text
id pubmed-3062114
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-30621142011-03-31 Monitoring of incidence, severity, and causality of adverse drug reactions in hospitalized patients with cardiovascular disease Kaur, Sharminder Kapoor, Vinod Mahajan, Rajiv Lal, Mohan Gupta, Seema Indian J Pharmacol Research Article BACKGROUND: Patients admitted to cardiology department are mostly on polypharmacy. So drug-drug interactions and adverse effects of drugs are quite common. Yet, there is a paucity of data regarding adverse drug reaction (ADR) monitoring in cardiology department in India. The present study is an effort to fill up these lacunae. MATERIALS AND METHODS: A prospective, observational study registering 966 indoor cardiology patients according to predetermined inclusion and exclusion criteria was conducted for one year. ADR profile was noted by spontaneous reporting and intensive monitoring. Naranjo ADR probability scale was used to establish the causality. RESULTS: A total of 208 ADRs were reported from 188 patients (19.5%). Of these 188 patients, 62 patients (33%) were hospitalized primarily due to the development of ADRs, while 126 (67%) patients developed ADRs during hospital stay. Nitrates were the most common offender drug group (17.8%). CONCLUSION: Development of ADR in one of every five cardiac patient points toward a grave situation, but a higher incidence of Type A reactions in cardiology department means that these can be avoided. Medknow Publications 2011-02 /pmc/articles/PMC3062114/ /pubmed/21455416 http://dx.doi.org/10.4103/0253-7613.75661 Text en © Indian Journal of Pharmacology http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Kaur, Sharminder
Kapoor, Vinod
Mahajan, Rajiv
Lal, Mohan
Gupta, Seema
Monitoring of incidence, severity, and causality of adverse drug reactions in hospitalized patients with cardiovascular disease
title Monitoring of incidence, severity, and causality of adverse drug reactions in hospitalized patients with cardiovascular disease
title_full Monitoring of incidence, severity, and causality of adverse drug reactions in hospitalized patients with cardiovascular disease
title_fullStr Monitoring of incidence, severity, and causality of adverse drug reactions in hospitalized patients with cardiovascular disease
title_full_unstemmed Monitoring of incidence, severity, and causality of adverse drug reactions in hospitalized patients with cardiovascular disease
title_short Monitoring of incidence, severity, and causality of adverse drug reactions in hospitalized patients with cardiovascular disease
title_sort monitoring of incidence, severity, and causality of adverse drug reactions in hospitalized patients with cardiovascular disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062114/
https://www.ncbi.nlm.nih.gov/pubmed/21455416
http://dx.doi.org/10.4103/0253-7613.75661
work_keys_str_mv AT kaursharminder monitoringofincidenceseverityandcausalityofadversedrugreactionsinhospitalizedpatientswithcardiovasculardisease
AT kapoorvinod monitoringofincidenceseverityandcausalityofadversedrugreactionsinhospitalizedpatientswithcardiovasculardisease
AT mahajanrajiv monitoringofincidenceseverityandcausalityofadversedrugreactionsinhospitalizedpatientswithcardiovasculardisease
AT lalmohan monitoringofincidenceseverityandcausalityofadversedrugreactionsinhospitalizedpatientswithcardiovasculardisease
AT guptaseema monitoringofincidenceseverityandcausalityofadversedrugreactionsinhospitalizedpatientswithcardiovasculardisease